VT
MEDP icon

Vise Technologies’s Medpace MEDP Stock Holding History

Vise Technologies’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$608K Buy
1,149
+781
+212% +$360K 0.01% 1043
2026
Q1 		$207K Hold
368
– – ﹤0.01% 1366
2025
Q4 		$207K Buy
+368
New +$209K ﹤0.01% 1377

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vise Technologies's MEDP Position: Q2 2026 in Review

Vise Technologies increased its Medpace (MEDP) stake by 212% in Q2 2026, buying an estimated $360K and bringing the position to 1,149 shares worth $608K. The position accounts for 0.01% of the portfolio, ranked #1043.

Vise Technologies first reported a position in MEDP in Q4 2025 and has held it in 3 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Vise Technologies held 1,149 shares of Medpace worth $608K as of Q2 2026.
  • Vise Technologies bought 781 Medpace shares in Q2 2026, an estimated $360K.
  • Medpace made up 0.01% of Vise Technologies's portfolio in Q2 2026, its #1043 holding.
  • Vise Technologies first reported a position in Medpace in Q4 2025 and has held it in 3 quarters since.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.